Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C
- 1 October 2015
- journal article
- research article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 26 (10) , 976-983
Abstract
No abstract availableKeywords
Funding Information
- Department of Health and Aged Care, Australian Government (2-D3X513)
- National Institutes of Health (R01DA015999)
- National Institute on Drug Abuse
- National Health and Medical Research Council
This publication has 40 references indexed in Scilit:
- The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugsDrug and Alcohol Dependence, 2013
- The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MDDrug and Alcohol Dependence, 2013
- Epidemiology and natural history of HCV infectionNature Reviews Gastroenterology & Hepatology, 2013
- Meta‐analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipmentAddiction, 2011
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet, 2011
- Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC StudyDrug and Alcohol Dependence, 2010
- Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus InfectionGastroenterology, 2010
- Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study)Drug and Alcohol Dependence, 2009
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disordersDrug and Alcohol Dependence, 2009